BDA advises Zoetis on the sale of its plant health business in Japan to Nippon Soda

BDA Partners ("BDA") acted as the exclusive financial advisor to Zoetis Inc, a leading animal health company, in connection with its agreement to divest its Plant Health business in Japan to Nippon Soda Co, Ltd.

BDA Deal Team
Jeff Acton, Managing Director, Tokyo
Toshiaki Yokohara, Director, Tokyo
Alissa Schneideman, Analyst, Tokyo

About BDA
BDA Partners is a leader in cross-border investment banking involving Asia. BDA advises on M&A and capital raising. BDA has been consistently owned and managed by the same team since 1996. BDA has a track record of providing independent advice to blue-chip corporate and financial sponsor clients from North America, Europe, and Asia. BDA is headquartered in New York with offices in London, Dubai, Mumbai, Ho Chi Minh City, Singapore, Hong Kong, Shanghai, Seoul, and Tokyo. BDA formed partnerships with William Blair & Company in 2011 and Development Bank of Japan in 2017. www.bdapartners.com

US securities transactions are performed by BDA Partners' affiliate, BDA Advisors Inc, a broker-dealer registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc. is a member of the Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorised and regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors.